HomeANRO • NYSE
add
Alto Neuroscience Inc
Previous close
$20.67
Year range
$1.60 - $25.17
Market cap
660.31M USD
Avg Volume
265.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.06M | 0.34% |
Net income | -16.18M | -6.45% |
Net profit margin | — | — |
Earnings per share | -0.45 | — |
EBITDA | -16.90M | -0.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 176.48M | 4.91% |
Total assets | 184.69M | 4.03% |
Total liabilities | 33.55M | 28.62% |
Total equity | 151.14M | — |
Shares outstanding | 31.95M | — |
Price to book | 4.37 | — |
Return on assets | -25.71% | — |
Return on capital | -27.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.18M | -6.45% |
Cash from operations | -11.52M | 11.56% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 50.18M | 102,318.37% |
Net change in cash | 38.67M | 387.02% |
Free cash flow | -6.86M | 27.96% |
About
Founded
2019
Website
Employees
68
